PMID: 42180166

Cagrilintide and CagriSema for weight reduction and metabolic risk modification in overweight or obesity: a systematic review and meta-analysis.

Rao Hammad, Kumar Sumet, Ali Sheikh Muhammad Ebtehaj, Asif Harmain Muhammad, Kumar Mukesh, Kumar Laksh, Raja Adarsh

Journal of diabetes and metabolic disorders · 2026

Vol. 25, Issue 1, pp. 140

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.